Toho Holdings Co (TSE:8129) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:8129 Toho Holdings Co Ltd TSE:8129
86 GF Score
Price 円4,101.00
GF Value 円4,809.72
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Toho Holdings Co FFO per Share?

FFO per Share only applies to REITs.

TSE:8129
86GF Score
Toho Holdings Co Ltd TSE:8129
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Toho Holdings Co (TSE:8129) Overvalued in 2026?

Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued. The current stock price of 円4,101.00 is trading 14.7% below its estimated GF Value™ of 円4,809.72. GuruFocus considers Toho Holdings Co to be Modestly Undervalued.

Key valuation signals for TSE:8129:

  • FFO per Share:
  • GF Value™: 円4,809.72 vs. price of 円4,101.00 (14.7% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the TSE:8129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Toho Holdings Co Business Description

Other Exchanges TON:Germany
Address 4-43-11 Daizawa, Setagaya-ku, Tokyo, JPN, 155-8655
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
86GF Score

Get the complete analysis for TSE:8129

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,101.00
Price
円4,809.72
GF Value